Susquehanna International Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-755,600
| Closed | -$9.4M | – | 10818 |
|
|
2016
Q4 | $9.4M | Buy |
755,600
+329,700
| +77% | +$3.97M | ﹤0.01% | 1613 |
|
|
2016
Q3 | $5.83M | Sell |
425,900
-241,300
| -36% | -$2.42M | ﹤0.01% | 2065 |
|
|
2016
Q2 | $4.93M | Buy |
667,200
+369,200
| +124% | +$2.77M | ﹤0.01% | 2217 |
|
|
2016
Q1 | $1.9M | Sell |
298,000
-781,200
| -72% | -$4.38M | ﹤0.01% | 3870 |
|
|
2015
Q4 | $6.75M | Buy |
1,079,200
+194,800
| +22% | +$1.28M | ﹤0.01% | 2164 |
|
|
2015
Q3 | $5.17M | Sell |
884,400
-71,600
| -7% | -$552K | ﹤0.01% | 2639 |
|
|
2015
Q2 | $7.91M | Sell |
956,000
-100,600
| -10% | -$890K | ﹤0.01% | 2275 |
|
|
2015
Q1 | $8.71M | Buy |
1,056,600
+299,400
| +40% | +$2.21M | ﹤0.01% | 2013 |
|
|
2014
Q4 | $5.2M | Buy |
757,200
+82,000
| +12% | +$513K | ﹤0.01% | 2826 |
|
|
2014
Q3 | $3.65M | Sell |
675,200
-215,100
| -24% | -$1.26M | ﹤0.01% | 3538 |
|
|
2014
Q2 | $5.67M | Sell |
890,300
-664,200
| -43% | -$4.57M | ﹤0.01% | 2876 |
|
|
2014
Q1 | $12.5M | Sell |
1,554,500
-4,500
| -0.3% | -$35K | 0.01% | 1742 |
|
|
2013
Q4 | $10.6M | Buy |
1,559,000
+1,307,900
| +521% | +$7.06M | ﹤0.01% | 1985 |
|
|
2013
Q3 | $4.62M | Buy |
251,100
+68,000
| +37% | +$1.32M | ﹤0.01% | 2856 |
|
|
2013
Q2 | $3.2M | Buy |
+183,100
| New | +$3.25M | ﹤0.01% | 3192 |
|
Other funds holding ARIA
Susquehanna International Group's ARIA Position: Q1 2017 in Review
Susquehanna International Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 11,138 shares — an estimated $139K sold.
Susquehanna International Group first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $18.7M in Q4 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Susquehanna International Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Susquehanna International Group sold 11,138 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $139K.
- Susquehanna International Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
- Susquehanna International Group's Ariad Pharmaceuticals Inc position peaked at $18.7M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.